LIAISON® ferritin - An automated chemiluminescent immunoassay for the determination of ferritin

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2739-2741

  König, Bernd ^a   Oed, M ^a   Kunz, A ^a   Schlett, R ^a   Mack, M ^a  

^a Byk Sangtec Diagnostica ^*  (Germany)

Author keywords

Chemiluminescence; Ferritin; Immunoassay; Tumor marker

Indexed keywords

FERRITIN;

ANALYZER; CHEMOLUMINESCENCE; CONFERENCE PAPER; IMMUNOASSAY; PRIORITY JOURNAL; ARTICLE; AUTOANALYSIS; BLOOD; CALIBRATION; FEMALE; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT;

AUTOANALYSIS; CALIBRATION; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FERRITINS; HUMANS; IMMUNOASSAY; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS;

EID: 0032586760     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Halliday CE, Halliday JW, Powell, LW: The clinical manifestation of chronic iron overload. Baillieres Clin Haematol 2: 401421, 1989.
2. Hann WH, Lange B, Stahlhu MW: Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer 66: 313-316, 1990.
3. Holyoake TL, Stott DJ, McKay PJ: Use of plasma ferritin concentration to diagnose iron deficiency in elderly patients. J Clin Pathol 46: 857-860, 1993.